Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT02295358
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of Ocular Hypertension or Open Angle Glaucoma of mild to moderate severity, with or without previously diagnosed dry eye syndrome, who are currently on monotherapy with a prostaglandin analog.
* Age 40-89 of either gender, of any race/ethnicity
Exclusion Criteria:
* Females who are currently pregnant or planning to become pregnant during the study period
* Age \<40 years old
* Diagnosis of any other form of glaucoma other than open-angle
* Patients with known hypersensitivity (i.e., anaphylactic reaction) to omega-3 fatty acids or any of its components
* Patients with cirrhosis or with known liver disease
* Patients with diagnosed celiac disease
* Patients with a hypersensitivity to fish or shellfish
* Patients with paroxysmal or persistent atrial fibrillation
* Patients who are currently using medical or recreational marijuana
* Patients currently on any anticoagulation therapy including warfarin, dabigatran, apixaban, rivaroxaban, clopidogrel, cilostazol, dipyridamole, prasugrel, ticlopidine, ticagrelor
* Patients currently on Lovaza, an omega- 3 fatty acid supplement requiring a prescription
* Patients with any recent ocular surgery or laser treatment within 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
89 Years
Study:
NCT02295358
Study Brief:
Protocol Section:
NCT02295358